Virginia Commonwealth University Health Aims to Stop Spread of Hospital Infections with DRX-Revolution Nano Mobile X-ray System

DRX-Revolution Nano Mobile X-ray System is helping Virginia Commonwealth University (VCU) Health System’s youngest patients in its Neonatal Intensive Care Unit (NICU) stay healthy.

An academic medical center, VCU Health installed the DRX-Revolution Nano as a unit dedicated solely to the NICU, in an effort to avoid the possible spread of hospital-acquired infection from adult patients on other hospital floors.

“Having one system dedicated to the floor will help reduce the chances of hospital-acquired infections going from patient to patient and room to room,” said Robert Jarvis III, Diagnostic Imaging Modality Manager at VCU Health.

The CARESTREAM DRX-Revolution Nano sits outside VCU Health’s NICU to fulfill its imaging orders. At only 220 pounds, the mobile system’s compact footprint allows for easy positioning in critical care units, while providing high-quality digital radiography imaging.

“We made the purchase with the mindset that it will support the NICU population in our hospital, and the small footprint makes it easy to get in and out of the rooms,” Mr. Jarvis added.

Special circumstances that surround these patients—it can be challenging to protect infants—made it necessary to have a unit standing by. Portable X-ray units can conduct exams on 20 to 30 patients on any given shift at VCU Health, Mr. Jarvis said. Using the same machine for procedures on both babies and adult hospital patients, who are admitted for various reasons, including serious diseases, could expose babies to other ailments.

Easy access to the DRX-Revolution Nano has helped staff at VCU Health respond to NICU patient needs quickly. Before VCU Health purchased the system, their technologists, like most hospitals, conducted exams based on location, charting routes according to need. A life-threatening page for an urgent exam could disrupt that flow.

“It’s a lot more convenient—and helps us respond better to our patients—with a machine already in place,” Mr. Jarvis said.

VCU Health has a large fleet of CARESTREAM DRX-Revolution Mobile X-ray Systems at its location in downtown Richmond, Va., as well as CARESTREAM DRX-Evolution Plus rooms and retrofitted rooms.

Carestream’s X-Factor platform lets facilities share the same wireless detector seamlessly across all Carestream DRX products and allows technologists to move easily between different systems with minimal training time, speeding up workflow and exams.

“The biggest advantage is the graphical user interface with the software,” said Mr. Jarvis, who also praised Carestream’s image quality. “I can train someone on the DRX-Evolution Plus because it’s the same software on the DRX-Revolution and the Nano. They can go to any Carestream system and pick it up right away.”

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”